K Number
K031629
Manufacturer
Date Cleared
2003-06-06

(10 days)

Product Code
Regulation Number
886.1120
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

Canon Non-Mydriatic Retinal Camera CR-DGi is intended to be used for taking pictures of retina of human eye without a mydriatic.

Device Description

CR-DGi is an improved model of CR5-45NM.

AI/ML Overview

The provided text describes Canon's CR-DGi Non-Mydriatic Retinal Camera. The device is an updated model of the Canon CR 45 NM, and its primary purpose is to capture images of the human retina without the need for pupil dilation. The 510(k) submission (K031629) focuses on demonstrating substantial equivalence to the predicate device.

However, the provided text does not contain information about acceptance criteria, a specific study proving device performance against acceptance criteria, sample sizes used, data provenance, number of experts, adjudication methods, MRMC studies, standalone performance, type of ground truth, or details about training set size and ground truth establishment for an AI/algorithm-based device.

The document is a 510(k) summary for a medical device that appears to be a hardware product (a camera), not an AI/algorithm. Therefore, the concepts of "acceptance criteria" and "study that proves the device meets the acceptance criteria" in the context of AI performance are not applicable here. The "performance" section in the comparison table refers to physical specifications and features (e.g., angle of view, working distance, focusing mechanism) rather than diagnostic accuracy metrics.

The FDA 510(k) clearance in this case is for a medical device (camera) demonstrating substantial equivalence in its specifications and intended use to a previously cleared predicate device.

Therefore, I cannot fulfill your request for information regarding acceptance criteria, study details, expert involvement, or AI-specific performance metrics as this information is not present in the provided text.

The document primarily states:

  • Proposed Device: Canon CR-DGi HKI, Ophthalmic camera
  • Predicate Device: Canon CR 45 NM 86HKI, Ophthalmic cameras (K980246)
  • Intended Use: Taking pictures of retina of human eye without a mydriatic.
  • Performance Comparison: A table comparing specifications between the proposed and predicate devices, showing "Same" for most critical imaging parameters (Angle of view, Min. diameter of pupil required, Working distance, Light source for photography). The primary change noted is the image unit shifting from supporting multiple options (EOS Digital Camera, 35mm film, Polaroid, 3CCD TV Camera) to solely EOS Digital Camera.
  • Regulatory Clearance: The FDA found the device substantially equivalent to the predicate device.

{0}------------------------------------------------

K031629

Section 7: Summary

510(k) Summary

Prepared:

April 16, 2003

Submitter:

Company Name: Canon USA, Inc. (U.S. agent for Canon Inc.) One Canon Plaza Company Address: Lake Success, NY 11042 Ms. Sheila Driscoll Contact Person: Phone Number: (516) 328-5602 Fax Number: (516) 328-5169

Proposed Device:

Reason For 510(k): Manufacturer: Trade Name: Model Name: Classification Name: FDA 510(k) #:

New Model Canon Inc. Canon CR-DGi HKI, Ophthalmic cameras To be assigned

Predicate Device: Manufacturer: Trade Name: Model Name: Classification Name: FDA 510(k) #:

Canon Inc. Canon CR 45 NM 86HKI, , Ophthalmic cameras K980246

Description Of Device: CR-DGi is an improved model of CR5-45NM.

CR-DGi is intended to be used for taking pictures of retina of human eye Intended Use: without a mydriatic.

{1}------------------------------------------------

K031629

Appendix D: Substantial Equivalence Comparison D-2 Table of comparison

CR6-45NMCR-DGi
Angle of view45° (37° when S.P switch is ON)Same
Actual image size$\phi$ 22mm (on 35mm film)$\phi$ 74mm (on Polaroid film)Same
Min. diameter of pupilrequired4.0mm -(3.7mm when S.P switch is ON)Same
PERFORMANCEWorking distance (WD)45mmSame
FocusingBy aligning the split linesSame
Data to be printedHand-written dataNone
Eye fixation lampInternal (during observation of eye frontimage and retinal image)Internal (during observation of eyefront image and retinal image)External
Light source forphotographyMax. 300WSSame
Image unitEOS Digital Camera (with Adapter)35mm film unitPolaroid film unit3CCD TV Camera (with Adapter)EOS Digital Camera
Working range
Vertical37mmSame
Forward & back40mmSame
Right & left100mmSame
Chin rest (vertically)70mmSame
External dimensionW325xL496xH570mmSame
WeightApprox. 24kgApprox. 23kg
Intended useTaking picture of retina of human eyeSame
Energy used300VASame
Energy deliveredNASame
Target populationOptometrist and OphthalmologistSame
Physical safetyUL544Same
Compliance with standardsUL544Same
BiocompatibilityNASame
Labeling PackagingPrinted model name is changed

. •••

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. Inside the circle is an abstract symbol resembling a stylized caduceus, featuring three human profiles facing to the right, with flowing lines beneath them.

Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JUN - 6 2003

Canon U.S.A., Inc. c/o Mr. Joseph Murnane Senior Staff Engineer Underwriters Laboratories, Inc. 1285 Walt Whitman Road Melville, NY 11747

Re: K031629

Trade/Device Name: Canon Non-Mydriatic Retinal Camera, Model CR-DGI Regulation Number: 21 CFR 886.1120 Regulation Name: Ophthalmic Camera Regulatory Class: Class II Product Code: HKI Dated: May 27, 2003 Received: May 27, 2003

Dear Mr. Murnane:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{3}------------------------------------------------

Page 2 - Mr. Joseph Murnane

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4613. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

A Kalipi Rosenthal

A. Ralph Rosenthal, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

Indications Statement

510(K)Number(if known):K031629
----------------------------------

Page 1 of 1

Device Name:CANON Non-Mydriatic RETINAL CAMERA CR-DGi
---------------------------------------------------------

Indications for Use:

.

Canon Non-Mydriatic Retinal Camera CR-DGi is intended to be used for taking pictures of retina of human eye without a mydriatic.

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHERT PAGE IF

NEEDED)

Concurrence of CDRH, Office of Device Evaluation(ODE)

Prescription Use(Per 21 CFR 801.109) OR Over-The-Counter Use
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

(Optional Format 1-2-96)

(Division Sign-Off)

Division of Ophthalmic Ear,
Nose and Throat Devises

510(k) NumberK031629
------------------------

/

§ 886.1120 Ophthalmic camera.

(a)
Identification. An ophthalmic camera is an AC-powered device intended to take photographs of the eye and the surrounding area.(b)
Classification. Class II (special controls). The device, when it is a photorefractor or a general-use ophthalmic camera, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 886.9.